| P50 | author | Philippa C Matthews | Q50981209 |
| | Pieter Jooste | Q58828253 |
| | Philip J. R. Goulder | Q72618990 |
| | Emily Adland | Q79069274 |
| | M Muenchhoff | Q87288667 |
| | Gareth Tudor-Williams | Q95647857 |
| | Alice Swordy | Q113126433 |
| P2093 | author name string | Leana Laker | |
| | Luisa Mori | |
| | Anna Csala | |
| | Masa Mori | |
| P2860 | cites work | Molecular and cellular insights into T cell exhaustion | Q26800047 |
| | Very early combination antiretroviral therapy in infants: prospects for cure | Q26830063 |
| | Two subsets of memory T lymphocytes with distinct homing potentials and effector functions | Q28146072 |
| | Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia | Q28254584 |
| | HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells | Q29616205 |
| | PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression | Q29618956 |
| | Low CD8 T-cell proliferative potential and high viral load limit the effectiveness of therapeutic vaccination | Q33884084 |
| | Young HIV-infected adults are at greater risk for medication nonadherence | Q33962940 |
| | Immunity to HIV in Early Life | Q34033051 |
| | Absence of detectable HIV-1 viremia after treatment cessation in an infant | Q34379777 |
| | Effect of caregivers' depression and alcohol use on child antiretroviral adherence in South Africa | Q35245327 |
| | Incomplete immune reconstitution despite virologic suppression in HIV-1 infected children and adolescents | Q35338750 |
| | Population-based hematologic and immunologic reference values for a healthy Ugandan population | Q35542336 |
| | Human immunodeficiency virus-specific CD8+ T-cell activity is detectable from birth in the majority of in utero-infected infants | Q36315692 |
| | Emergence of polyfunctional CD8+ T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy | Q36498230 |
| | Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa | Q37226114 |
| | Reduction in perinatal HIV infections in KwaZulu-Natal, South Africa, in the era of more effective prevention of mother to child transmission interventions (2004-2012). | Q38397533 |
| | Adolescents with HIV and transition to adult care in the Caribbean, Central America and South America, Eastern Europe and Asia and Pacific regions. | Q38681064 |
| | Adolescent antiretroviral management: Understanding the complexity of non-adherence | Q38758919 |
| | Paediatric HIV infection: the potential for cure | Q38773102 |
| | Nonprogressing HIV-infected children share fundamental immunological features of nonpathogenic SIV infection | Q39278529 |
| | Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study | Q39669029 |
| | Factors influencing T cell activation and programmed death 1 expression in HIV-infected children | Q39718609 |
| | HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report | Q40834710 |
| | Early antiretroviral therapy in children perinatally infected with HIV: a unique opportunity to implement immunotherapeutic approaches to prolong viral remission | Q41102458 |
| | Are infants unique in their ability to be "functionally cured" of HIV-1? | Q42234163 |
| | Response to highly active antiretroviral therapy varies with age: the UK and Ireland Collaborative HIV Paediatric Study. | Q44129942 |
| | Response to combination antiretroviral therapy: variation by age. | Q44396687 |
| | Antiretroviral therapy outcomes in resource-limited settings for HIV-infected children <5 years of age. | Q44821212 |
| | Functional patterns of HIV-1-specific CD4 T-cell responses in children are influenced by the extent of virus suppression and exposure | Q45409477 |
| | Reconstitution of virus-specific CD4 proliferative responses in pediatric HIV-1 infection | Q45705725 |
| | Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial | Q45731634 |
| | Immunoreconstitution after ritonavir therapy in children with human immunodeficiency virus infection involves multiple lymphocyte lineages | Q45749690 |
| | High frequency of rapid immunological progression in African infants infected in the era of perinatal HIV prophylaxis | Q46175630 |
| | Immunological recovery and metabolic disorders in severe immunodeficiency HIV type 1-infected children on highly active antiretroviral therapy | Q46238904 |
| | Restoration of the CD4 T cell compartment after long-term highly active antiretroviral therapy without phenotypical signs of accelerated immunological aging | Q49167316 |
| | Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies. | Q51998139 |
| | Immune repopulation after HAART in previously untreated HIV-1-infected children. Paediatric European Network for Treatment of AIDS (PENTA) Steering Committee. | Q52027512 |
| | HIV: Shock and kill. | Q55056512 |
| | Long-Term Effects of Highly Active Antiretroviral Therapy in Pretreated, Vertically HIV Type 1-Infected Children: 6 Years of Follow-Up | Q57276223 |
| | Cytotoxic granule release dominates gag-specific CD4+ T-cell response in different phases of HIV infection | Q61928277 |
| | Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells--a mechanism of immune evasion? | Q71840957 |
| | HIV-1-specific cytotoxic T lymphocyte responses in the first year of life | Q72896097 |
| | HIV-1 replication increases HIV-specific CD4+ T cell frequencies but limits proliferative capacity in chronically infected children | Q73419672 |
| | Gag-specific CD4+ T-cell responses are associated with virological control of paediatric HIV-1 infection | Q83906060 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | anti-retroviral agent | Q50430310 |
| P304 | page(s) | 1413-1422 | |
| P577 | publication date | 2018-05-03 | |
| P1433 | published in | AIDS | Q4651863 |
| P1476 | title | Recovery of effective hiv-specific cd4+ t-cell activity following antiretroviral therapy in paediatric infection requires sustained suppression of viraemia. | |
| P478 | volume | 32 | |